Global Drug Discovery Market Forecast 2022-2030
KEY FINDINGS
The global drug discovery market is projected to register a CAGR of 6.58% during the forecast period, 2022-2030. The increasing R&D efforts for multiple diseases cure and the technological advancements are the primary factors propelling the market growth.
MARKET INSIGHTS
Drug discovery entails identifying the potential new medicines in a vast range of scientific disciplines like pharmacology, chemistry, and biology. The drug discovery process landscape has witnessed radical changes with innovative methods and technologies for drug development. This has enabled research organizations and pharmaceutical companies to find solutions and cures for several diseases and health conditions. In addition, companies are introducing nanotechnology, biochips, automated processes, cloud computing, and artificial intelligence.
At the same time, the process of new drug discovery and development needs almost 10-15 years, encompassing preliminary research to introducing drugs to the market. Also, there are risks associated with any development phase that must be considered.
Geographically, the European and North American countries have excelled for decades in drug discovery, majorly attributed to awareness programs, government & CRO initiatives, pharmaceutical companies, etc. The market growth restraining factors include project feasibility & success rate, highly regulated market, and time-consuming process.
REGIONAL INSIGHTS
The global drug discovery market growth analysis includes the geographical assessment of North America, Europe, Asia-Pacific, and Rest of World. North America is the leading region with regard to the highest revenue share, mostly attributed to advancements in various technologies.
COMPETITIVE INSIGHTS
The intense competitive rivalry is due to the collaborations, partnerships, and fund projects among new market players. Some of the leading companies in the market include Roche AG, Eli Lilly and Company, Johnson & Johnson, Novartis AG, etc.
Our report offerings include:
Explore key findings of the overall market
Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
Market Segmentation cater to a thorough assessment of key segments with their market estimations
Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments
- 1. Research Scope & Methodology
- 1.1. Study Objectives
- 1.2. Scope Of Study
- 1.3. Methodology
- 1.4. Assumptions & Limitations
- 2. Executive Summary
- 2.1. Market Size & Estimates
- 2.2. Market Overview
- 3. Market Dynamics
- 3.1. Key Drivers
- 3.1.1. Growing R&D For Tackling Several Diseases
- 3.1.2. Technological Advancements
- 3.2. Key Restraints
- 3.2.1. Extensive Time-consuming Process
- 3.2.2. Highly Regulated Market
- 3.2.3. Project Feasibility And Success Rate
- 4. Key Analytics
- 4.1. Impact Of Covid-19 On Global Drug Discovery Market
- 4.2. Key Market Trends
- 4.3. Porter’s Five Forces Analysis
- 4.3.1. Buyers Power
- 4.3.2. Suppliers Power
- 4.3.3. Substitution
- 4.3.4. New Entrants
- 4.3.5. Industry Rivalry
- 4.4. Opportunity Matrix
- 4.5. Drug Discovery And Development Process
- 4.5.1. Drug Discovery And Development
- 4.5.2. Preclinical Research
- 4.5.3. Clinical Research
- 4.5.4. Regulatory Authority Review
- 4.5.5. Post Market Safety Monitoring
- 4.6. Regulatory Framework
- 5. Market By Drug Type
- 5.1. Small Molecule Drug
- 5.2. Biologic Drug
- 6. Market By Service
- 6.1. Chemical Services
- 6.2. Drug Metabolism And Pharmacokinetics Services
- 6.3. Biological Services
- 6.4. Other Pharmaceutical Services
- 7. Market By End-users
- 7.1. Pharmaceutical Companies
- 7.2. Contract Research Organizations
- 7.3. Research Institutes
- 7.4. Other End-users
- 8. Market By Technology
- 8.1. High Throughput Screening
- 8.2. Spectroscopy
- 8.3. Combinatorial Chemistry
- 8.4. Biochips
- 8.5. Pharmacogenomics And Pharmacogenetics
- 8.6. Bioinformatics
- 8.7. Metabolomics
- 8.8. Nanotechnology
- 8.9. Other Technologies
- 9. Geographical Analysis
- 9.1. North America
- 9.1.1. Market Size & Estimates
- 9.1.2. Key Growth Enablers
- 9.1.3. Key Challenges
- 9.1.4. Key Players
- 9.1.5. Country Analysis
- 9.1.5.1. United States
- 9.1.5.2. Canada
- 9.2. Europe
- 9.2.1. Market Size & Estimates
- 9.2.2. Key Growth Enablers
- 9.2.3. Key Challenges
- 9.2.4. Key Players
- 9.2.5. Country Analysis
- 9.2.5.1. United Kingdom
- 9.2.5.2. Germany
- 9.2.5.3. France
- 9.2.5.4. Italy
- 9.2.5.5. Russia
- 9.2.5.6. Spain
- 9.2.5.7. Scandinavia
- 9.2.5.8. Rest Of Europe
- 9.3. Asia-pacific
- 9.3.1. Market Size & Estimates
- 9.3.2. Key Growth Enablers
- 9.3.3. Key Challenges
- 9.3.4. Key Players
- 9.3.5. Country Analysis
- 9.3.5.1. China
- 9.3.5.2. Japan
- 9.3.5.3. India
- 9.3.5.4. South Korea
- 9.3.5.5. Indonesia
- 9.3.5.6. Singapore
- 9.3.5.7. Taiwan
- 9.3.5.8. Australia & New Zealand
- 9.3.5.9. Rest Of Asia-pacific
- 9.4. Rest Of World
- 9.4.1. Market Size & Estimates
- 9.4.2. Key Growth Enablers
- 9.4.3. Key Challenges
- 9.4.4. Key Players
- 9.4.5. Regional Analysis
- 9.4.5.1. Latin America
- 9.4.5.2. Middle East & Africa
- 10. Competitive Landscape
- 10.1. Key Strategic Developments
- 10.1.1. Mergers & Acquisitions
- 10.1.2. Product Launches & Developments
- 10.1.3. Partnerships & Agreements
- 10.1.4. Business Expansions & Divestitures
- 10.2. Company Profiles
- 10.2.1. Agilent Technologies Inc
- 10.2.2. Astrazeneca Plc
- 10.2.3. Bayer Ag
- 10.2.4. Charles River Laboratories International Inc
- 10.2.5. Eli Lilly And Company
- 10.2.6. Evotec Se
- 10.2.7. Glaxosmithkline Plc
- 10.2.8. Icon Plc
- 10.2.9. Iqvia Holdings Inc
- 10.2.10. Johnson & Johnson
- 10.2.11. Merck & Co Inc
- 10.2.12. Novartis Ag
- 10.2.13. Pfizer Inc
- 10.2.14. Roche Ag
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook